Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Light & Wonder | LNW | Nov 22, 2024 | 96.42 | +2.13 |
Lightbridge | LTBR | Nov 22, 2024 | 6.30 | -7.49 |
LightInTheBox Holding ADR | LITB | Nov 22, 2024 | 2.03 | -1.46 |
LightPath Technologies A | LPTH | Nov 22, 2024 | 1.49 | -0.67 |
Lightspeed Commerce | LSPD | Nov 22, 2024 | 17.74 | +0.40 |
Lightwave Logic | LWLG | Nov 22, 2024 | 2.98 | +4.75 |
Lilium N.V. A | LILM | Nov 22, 2024 | 0.08 | 0.00 |
Limbach | LMB | Nov 22, 2024 | 102.64 | +3.68 |
Limoneira | LMNR | Nov 22, 2024 | 27.49 | -0.11 |
Lincoln Educational Services | LINC | Nov 22, 2024 | 16.15 | +3.53 |
Lincoln Electric | LECO | Nov 22, 2024 | 213.52 | +2.40 |
Lincoln National | LNC | Nov 22, 2024 | 35.34 | +1.49 |
Lincoln National Pref | LNC-D | Nov 22, 2024 | 27.97 | +0.58 |
Lindblad Expeditions | LIND | Nov 22, 2024 | 12.85 | +0.63 |
Linde | LIN | Nov 22, 2024 | 454.78 | -0.06 |
Lindsay | LNN | Nov 22, 2024 | 130.40 | -0.24 |
Lineage | LINE | Nov 22, 2024 | 64.10 | +1.83 |
Lineage Cell Therapeutics | LCTX | Nov 22, 2024 | 0.50 | -16.02 |
Linkage Global A | LGCB | Nov 22, 2024 | 0.23 | -0.66 |
Linkbancorp | LNKB | Nov 22, 2024 | 7.58 | +3.41 |
Lion ADR | LGHL | Nov 22, 2024 | 0.19 | -0.97 |
Lion Electric | LEV | Nov 22, 2024 | 0.22 | -7.83 |
Lionheart Units | CUBWU | Nov 22, 2024 | 10.07 | +0.00 |
Lions Gate Entertainment A | LGF-A | Nov 22, 2024 | 7.94 | -2.70 |
Lions Gate Entertainment B | LGF-B | Nov 22, 2024 | 7.08 | -1.94 |
Lipella Pharmaceuticals | LIPO | Nov 22, 2024 | 2.63 | +8.68 |
Lipocine | LPCN | Nov 22, 2024 | 5.15 | +3.00 |
LiqTech International | LIQT | Nov 22, 2024 | 1.67 | +1.83 |
Liquidia | LQDA | Nov 22, 2024 | 10.65 | +4.93 |
Liquidity Services | LQDT | Nov 22, 2024 | 25.40 | +0.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.